Concepedia

Ashwini Arunachalam

AA

Statistics

Publications

10

Citations

451

H-Index

10

Active since

2017

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The Ohio State University

NTT Medical Center

Hospital La Paz Institute for Health Research

Hospital Universitario La Paz

Ashwini Arunachalam is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, non-small cell lung cancer therapy, and non-small cell lung cancer treatment.

ORCID

Publications per year

2017–2025

10

Publications

10

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

Amy P. Abernethy, Ashwini Arunachalam, Thomas Burke et al. · PLoS ONE · 2017 · 95 citations · Full text

, , +17

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study

Ming‐Sound Tsao, Karl-Otto Kambartel, Hiroshi Isobe et al. · PLoS ONE · 2018 · 94 citations · Full text

, , +17

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study

P. Tagliaferri, Vladmir Cláudio Cordeiro de Lima, Say Ng et al. · European Journal of Cancer Care · 2017 · 62 citations · Full text

, , +17

Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study

Marisa A. Bittoni, Ashwini Arunachalam, Haojie Li et al. · Clinical Lung Cancer · 2018 · 55 citations · Full text

, , +17

Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer

Ashwini Arunachalam, Haojie Li, Marisa A. Bittoni et al. · Clinical Lung Cancer · 2018 · 50 citations · Full text

, , +16

1–5 of 10